Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.
about
Management of exfoliative glaucoma: challenges and solutionsDirected therapy for exfoliation syndromeIntraocular pressure and ocular hemodynamics in patients with primary open-angle glaucoma treated with the combination of morning dosing of bimatoprost and dorzolamide hydrochloride.Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionThe additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucoma.Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360° synechial angle-closure glaucoma: a preliminary studyA pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertensionPreservative-free tafluprost in the treatment of naive patients with glaucoma and ocular hypertension.Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trialsDaily costs of prostaglandin analogues as monotherapy or in fixed combinations with timolol, in Denmark, Finland, Germany and SwedenBimatoprost - a review.A review of the use of latanoprost for glaucoma since its launch.Efficacy and safety of bimatoprost in glaucoma and ocular hypertension in non-responder patients.Genetics, Diagnosis, and Monitoring of Pseudoexfoliation Glaucoma.Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome.Optimal sampling scheme for estimation of intraocular pressure diurnal curves in glaucoma trials.24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma.Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension.Pharmacotherapy of glaucoma: new opportunities, old challenges.
P2860
Q28081245-9806B6CF-EF0C-45CA-929A-DA1298D550E5Q33514847-F01BA76F-7B34-4CA1-9EDE-5DA2F5A33143Q33790393-0605F8C0-812D-48D5-BCF1-EADF89AEC95CQ34043309-CB770A81-4745-4437-8544-27F94F7FD008Q34296286-60101C9E-8C1D-46EC-84FD-08BEBD843D43Q34545031-4D3398CF-8EAA-4EA1-A9E3-DDABE82F1192Q35036839-90E30A89-5061-469B-A6D9-BEF2DB16AA1CQ36873329-FAF7E709-E68D-40BE-B23E-38585EA86F72Q37091331-6F6621C5-D9AA-4DAD-AE0B-5E9644DE9B01Q37318853-A502E84F-1128-4216-861F-37FD1DCE3323Q37623833-3362714B-5F6A-42C7-A517-55996406FAB9Q37986149-2A023125-9E7C-4A29-B233-66B0401B999CQ38598695-10F72BCF-84B5-4A2A-A324-1FD3F93B7BB6Q39305967-7179C7C5-5F6B-407A-9981-1329E07FAF93Q42022092-3890EA70-016C-4AE9-A362-B5E14666859DQ42683473-FE6D427F-1154-4844-9243-96E1E9155EBBQ45759968-4D439939-68D5-4F4C-BAD0-9A9803420EAAQ53079997-611FC9F7-FABE-4DC7-9D47-B78901EE9E0CQ53135285-7B276AE3-A7F2-47D0-B8D8-10098A1F1CFE
P2860
Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Diurnal IOP control with bimat ...... er-masked, three-centre study.
@en
type
label
Diurnal IOP control with bimat ...... er-masked, three-centre study.
@en
prefLabel
Diurnal IOP control with bimat ...... er-masked, three-centre study.
@en
P2093
P2860
P356
P1476
Diurnal IOP control with bimat ...... er-masked, three-centre study.
@en
P2093
A G P Konstas
M Goldenfeld
P2860
P304
P356
10.1136/BJO.2006.106690
P407
P577
2006-11-23T00:00:00Z